Implant Sciences Corporation (OTCQB: IMSC) is a leader in the development and manufacture of advanced detection technologies designed to counter and eliminate the ever-evolving threats presented by explosives and drugs. The company’s explosives trace detection (ETD) and drugs trace detection solutions target a wide variety of vital security applications – including aviation, transportation, customs, air cargo, critical infrastructure protection, port and border protection, public safety and emergency first responders. Since its founding in 1984, Implant Sciences has recorded a rich history of innovation in several markets, such as medical products and semiconductor manufacturing, however, in 2008, the company restructured to become a pure play in the global Security Safety and Defense (SS&D) markets.

Over the past decade, Implant Sciences’ team of dedicated trace detection experts has leveraged an expansive intellectual property portfolio in order to develop proprietary technologies addressing unmet needs in the global SS&D industry. To date, the company’s patented technology, used in flagship products such as the QS-H150 handheld explosives trace detector and the QS-B220 desktop explosive and drugs trace detector, has been sold in more than 50 countries around the globe. Additionally, Implant Sciences’ ETDs have received approvals and certifications from several international regulatory agencies – including the Transportation Security Administration in the United States; the European Civil Aviation Conference; the Ministry of Public Safety and the Civil Aviation Administration of China; and the Federal Security Service of the Russian Federation, among others.

In the months to come, Implant Sciences will look to draw on its considerable experience in advanced ion technologies in order to further refine and expand upon its impressive catalog of trace detection technologies. This progress should strategically position the company to continue capitalizing on the projected growth of the global ETD market for the foreseeable future.

According to a report (http://dtn.fm/P5a4H) from leading international market and technology research firm Homeland Security Research, the global ETD market – including systems, sales, services, consumables and upgrades – will present multibillion-dollar business opportunities through 2020, expanding at a compound annual growth rate (CAGR) of 12.7 percent. Key to this growth will be strong demand from the Asia-Pacific region, driven by factors such as a massive investment in new airports and public security by the Chinese government, counterterror investments from the Indian government and strict legislations from the U.S. and European Union regarding cargo screenings on international passenger flights from the region. In total, the Asia-Pacific ETD market is on pace to achieve a CAGR of roughly 15 percent over the seven-year period ending in 2020.

In its latest financial report, released earlier this month, Implant Sciences gave prospective investors a preview of its potential in these favorable market conditions. During the fiscal quarter ended December 31, 2015, the company achieved a year-over-year increase in revenues in excess of 380 percent, recording $10.3 million for the three-month period. The bulk of this growth was attributed to the delivery of a substantial order with the U.S. Transportation Security Administration, increased shipments to European airports and increased shipments to Asia, Africa and South America. The result was an 818 percent increase in the number of QS-B220 desktop units sold, as compared to the same period in 2014.

By achieving strong revenue growth, Implant Sciences is effectively demonstrating its capabilities from not only a manufacturing and supply chain perspective, but also from a working capital management perspective. In a recent news release, Dr. William McGann, chief executive officer of Implant Sciences, echoed this optimism when discussing the company’s recent progress toward becoming self-sufficient, reiterating the tremendous potential offered to prospective shareholders by this pure play in the global SS&D industry in the coming years.

“Thus far this year, we have successfully self-funded the significant working capital required to deliver the record revenues being reported today,” he stated. “We’re continuing to invest and expect to increase our investment in technology, with the intent [to] introduce new product that will increase the size of the security market we can penetrate.”

For more information, visit www.implantsciences.com

Giggles N’ Hugs (OTCQB: GIGL) is going places with its fine-dining rooms, organic-food menus and adventure-filled play spaces for kids. The company is presently negotiating with the top four U.S. mall owners, who are ‘yearning’ to have Giggles N’ Hugs in their malls and are prepared to offer cash upfront to fund between 60 and 70 percent of opening costs. As consumers have increasingly been purchasing online, traffic by shoppers to malls has slowed. Mall owners want businesses that can generate excitement and foot traffic, and Giggles N’ Hugs fits that bill. Its three establishments, at Westfield Mall in Century City, Westfield Topanga Shopping Center, and the Glendale Galleria, have attracted the attention of People magazine, E! Online, Hollywood Life, Bloomberg Businessweek, the New York Post and many other print and online publications.

As CEO Joey Parsi explained recently, just as in other retail operations, location is, perhaps, the most important factor in the restaurant business. Giggles N’ Hugs is in the enviable position of having an extensive choice of locations, since it is such a magnet for mall foot traffic. Together, the major four mall owners present a wide-ranging, appetizing menu of over 550 domestic and international locations. The largest player, the Simon Property Group (NYSE: SPG), operates over 350 malls, including 17 overseas. The no. 2, General Growth Properties (NYSE: GGP), has over 120 properties. Westfield (OTC: WEFIF), the no. 3, has 32 shopping centers in the U.S., and Macerich (NYSE: MAC), the no. 4, has over 50 properties.

The company is beefing up its capital as it considers these invitations. It recently engaged investment bank Chardan Capital Markets, and it aims to raise $5 million through a 506(c) offering. Rule 506(c) under Regulation D is one of several ways an offering of securities may qualify for an exemption from the registration requirements of the Securities Act of 1933. It was created to implement Section 201(a) of the JOBS Act with the object of eliminating the prohibition on using general solicitation under, what is now, Rule 506(b). Rule 506(b) provides a “safe harbor” for a private offering under the Securities Act, i.e., it provides specific requirements that, if followed, establish that a transaction falls within the Section 4(a)(2) registration exemption.

However, under Rule 506(b), an issuer must not use general solicitation or advertising to market the securities nor sell securities to more than 35 non-accredited investors, among other stipulations. Rule 506(c) changes those two limbs of the rule by allowing general advertising but stipulates that only accredited investors must be contracted with. It also imposes a stricter standard to ensure that only accredited investors are contracted with. For a natural person to qualify as an accredited investor, he and his spouse must together have a net worth exceeding $1,000,000, excluding the value of the primary residence. Alternatively, he must have an annual income of over $200,000 in each of the two most recent years or joint income with his spouse in excess of $300,000 in each of those years and have a reasonable expectation of reaching the same income level in the current year.

With some cash to spend and so many invitations to dance, Joey Parsi’s biggest problem in the coming months may be deciding who is the most attractive partner.

Learn more by visiting www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

The Dominovas Energy Corporation (OTCQB: DNRG) is at the forefront of the alternative energy industry with its innovative RUBICON™ solid oxide fuel cell (SOFC). Fuel cells are an efficient, combustion-less, reliable, and virtually pollution-free energy source that provide electricity to power a wide array of applications, including buildings (manufacturing facilities, hotels and hospitals), primary power for grid integration, automobiles, emergency back-up systems, and base load grid power. A fuel cell utilizes the extraction of hydrogen from hydrocarbons such as natural gas to produce electricity. In principle, a fuel cell is an electrochemical device that operates like a battery. However, unlike a battery, a fuel cell requires re-fueling, not recharging. Fuel cells will continue to produce electricity and heat as long as there is a constant fuel source. The RUBICON™ works simply, has no moving parts, and operates silently, with water and excess heat as its only by-products. Consequently, the RUBICON™ provides the ideal solution for a myriad of electric power generation applications.

Dominovas Energy has identified marketing and sales opportunities for fuel cells in frontier market countries, where electricity supply is frequently unreliable, antiquated, and expensive, as compared to the cost of electricity and the production, thereof, in the United States. Dominovas Energy works with host nations’ governments. Initial project sizes range from 3 to 200 Megawatts (MW), with eventual project sizes of up to 3,000 MW. Project cost projections range from $25 million and beyond. Dominovas Energy will provide power to the local utilities under Power Purchase Agreements (PPAs), and, prior to deployment, it requires specific guarantees, bonding or other credit support, as necessary, where the local contracting entities do not enjoy strong credit ratings.

Backing up this bold strategy is the Dominovas Power management team. Heading the team is Neal Allen, Dominovas’s chairman, president and CEO. Prior to joining Dominovas Energy Corporation, Allen was CEO of Dominovas Energy, LLC from its inception in 2007 to the time of its merger with Western Standard Energy Group in February 2014. Allen also served as the chairman of Private Asset Group, LLC from 2002 to 2007. Emilio De Jesus is a board member of Dominovas Energy. He worked at Verizon Communications from 2000 to 2010 in many positions, including that of systems development manager. From 2012 to 2013, he was a director of Grupo Jemilce. Dominovas Energy’s chief operating officer is Michael Watkins. Previously, Watkins was vice president and managing member of Dominovas Energy, LLC from 2007 until the merger with Western Standard Energy Group.

Dr. Shamiul Islam is executive VP of fuel cell operations. Dr. Islam is one of the foremost experts on SOFC technology. His expertise extends to SOFC materials, research and their development. His knowledge of the design and construction of bench scale testing systems for high temperature chemical reactions is unparalleled in the industry. He has two registered patents in his name. Dr. Islam worked at the University of Calvary as a postdoctoral fellow in the Dept. of Chemical & Petroleum Engineering during the period from July 2013 – April 2014. He received his PhD in chemical engineering from the University of Calgary, Canada.

Eric Fresh is senior vice president of finance and investments. With more than 15 years in investment banking, private equity and corporate advisory services, Fresh has extensive experience in the execution of special situation transactions involving structured debt and equity financings for project finance. As senior vice president, Fresh will lead and manage Dominovas’s capital investment and deployment program for financing the company’s power projects. Before joining Dominovas Energy, Fresh founded E&K Partners, where he focused exclusively on value creation for middle-market companies, providing strategic management and structured finance advisory services for corporate restructurings, mergers and acquisitions, project finance and operations management. Prior to E&K Partners, he worked at GE Capital, where he managed $2.5 billion in upstream oil and gas assets located throughout the continental U.S. and structured and invested more than $1.8 billion in debt and equity transactions across various energy and industrial sectors. Additionally, he has held various executive positions with investment and merchant banking firms, including Morgan Stanley and Salomon Smith Barney.

Rounding out the team is Spero Plavoukos, who sits on the board of directors. Plavoukos is currently serving as vice president of Pacific Design Center, which houses the West Coast’s top decorating and furniture market, with showrooms, public and private spaces, a branch of the Museum of Contemporary Art (MOCA) and two restaurants operated by chef and restaurateur Wolfgang Puck.

Dominovas Energy is set to realize its vision of being a global leader in SOFC development. With its cutting-edge technology and experienced management team, the company may just be known around the world in 80 days.

For more information, visit www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

Moxian, Inc. (OTCQB: MOXC) specializes in precision marketing. For six years, the company has fixed its attention on enabling business owners to engage in high-level, targeted marketing. How? Moxian has combined a customer relations management tool with data analysis capabilities to offer a comprehensive solution — an online-to-offline platform — that incorporates social media and business for small- and medium-sized enterprises largely based in China.

Moxian offers social customer relationship management, marketing, event hosting, vouchers and product listings services, in addition to actionable reports. By allowing merchant clients to study consumer behavior, Moxian’s products and services have also been generating repeated interactions between users and merchant clients.

With the company’s User App, users gain access to a social media platform that comes complete with a package of services, including:

• a news center;
• a voice chat service called MO-Talk;
• a game center that enables users to play games and earn Moxian-sponsored MO-Points;
• a variety of merchant stores, which enable users to shop at the company’s merchant clients’ stores via the use of mobile devices; and
• MO-Shake, a service that allows users to shake their phone to win merchant-sponsored vouchers, Moxian-sponsored MO-Coins or MO-Points, as well as coupons, discounts, or admission to other events hosted by merchant clients.

Moxian also has a Business App. This app allows merchants to oversee their presence within the platform. It also allows the company’s merchant clients to open an e-commerce shop, plan a marketing campaign, interact with customers, offer rewards and discounts, manage payments and receive analytics.

Moxian’s innovative platform, plus its corresponding loyalty program, has been driving its significant growth. Last month, Moxian Technologies (Beijing) Co., a subsidiary of Moxian, Inc., revealed that, per a five-year cooperation agreement, it would become the sole reseller of ad space for Xinhua New Media Culture Communication Co. in the gaming industry. It would also become the sole information and operations partner in the gaming platform of the Xinhua New Media App.

This deal shows promise for both companies. It creates a new source of revenue for Moxian, laying a solid foundation for the company’s future growth, and it could help drive the Moxian App into the mainstream. As an exclusive gaming partner for the Xinhua New Media App, which has over 100 million users with 10 million daily active users, Moxian can leverage this opportunity to promote its games on the platform while acquiring a large number of young, active users for the Xinhua App.

The deal will also strengthen Moxian’s partnership with Xinhua New Media Centre. While marketing the Xinhua App, Moxian will assist in ramping up user engagement and getting users to read and click on Xinhua ads for Moxian rewards. Users of the app will be rewarded with Mo-Coins and Mo-Points when they participate and click on any ads. They can then redeem those Mo-Coins and Mo-Points for rewards by simply logging into the Moxian Platform.

For more information, visit the company’s website at www.Moxian.com

Let us hear your thoughts: Moxian, Inc. Message Board

Smartphones are attached to everyone’s hip in today’s world. Mobile payment solutions, such as PayPal (NASDAQ: PYPL) and Apple Pay, are being integrated into every new technology that emerges. When you launch an online store, the most important function of the website is the payment option. Today’s world moves at light speed and consumers demand instant gratification to their impulse buying via Amazon (NASDAQ: AMZN), eBay (NASDAQ: EBAY), Alibaba (NYSE: BABA), Craigslist, etc.

The contactless payments market is expected to have a value of $9.88 billion by 2018. This market includes payments via mobile handsets, smart cards, and key fobs, as well as consultation services, integration services, and value added services. The verticals associated with this market are as follows: banking, financial services and insurance; consumer goods and retail; healthcare; government and public sector; telecom and IT; and transportation and logistics. Alternet Systems, Inc. (OTCQB: ALYI) is in this business dynamic.

Alternet offers payment technology solutions to financial organizations that need a wide range of payment options for their customers. These products can be used across many devices, such as point of sale, cell phones, PCs, tablets, and web applications.

The entry of technology giants such as Apple (NASDAQ: AAPL), Samsung (OTC: SSNLF) and Google (NASDAQ: GOOG) to the mobile payments market has reignited the debate about the future of mobile payments. While the launch of Apple Pay, Samsung Pay and Android Pay have attracted much of the attention from the media, the real growth in the mobile payments industry in 2015 has come from elsewhere.

New research from Timetric finds that transaction value on the aforementioned mobile payment solutions is still relatively small. “For comparison, the value of Apple Pay transactions in 2015 was lower than the value of transactions on Kenyan M-Pesa,” says Vladimir Vukicevic, lead analyst at Timetric’s Cards & Payments Intelligence Centre.

“Two Chinese payment solutions, Alipay and Tenpay, dominate the global mobile payments market in terms of value of transactions. PayPal is, however, the leader in mobile payments in markets outside China,” continued Vukicevic.

The latest research from Timetric finds, however, that Apple Pay and Android Pay are in a good position to become the market leaders for in-store mobile payments. On the other hand, Alipay and PayPal are likely to remain leaders in remote mobile payments moving forward. They are also expected to become serious contenders for in-store payments.

Alternet Systems is well positioned in a rapidly growing space and has more than a century of experience in its management team, which will be invaluable as the company continues to adapt and grow in the months to come.

For more information, visit www.alternetsystems.com

Let us hear your thoughts: Alternet Systems, Inc. Message Board

Lithium ion batteries are more widely used than ever before. To illustrate this fact, consider the recent rise in production by Tesla Motors, Inc. (NASDAQ: TSLA), the automotive company behind a line of luxury electric cars, electric vehicle powertrain components and other battery products. Following the launch of its $5 billion Gigafactory focused on improving traditional lithium ion batteries, Tesla expects to have the ability to produce more lithium ion batteries each year than were manufactured worldwide in 2013, according to a report from Fox Business.

This sharp increase in production capacity will likely be met with an equally strong rise in demand. Leading global research firm Research and Markets forecasts the industry sustaining a compound annual growth rate of 14.4 percent in the seven year period ending 2019, leading to a global market value in excess of $33.1 billion. While major industry players such as Tesla are making advances toward bringing the benefits of this growth back to the United States, a large majority of currently-available lithium ion batteries and related products are imported from factories in China and Southeast Asia.

The dangers of substandard lithium ion batteries are well documented. Despite the fact that roughly 30 percent of the 5.5 billion cell phone batteries produced each year are shipped by air, according to a report by the Insurance Journal, an increasing number of passenger and freight airlines – including both United Airlines (NYSE: UAL) and Delta (NYSE: DAL) – have taken steps to ban bulk shipments of lithium ion batteries following reports that these storage solutions contributed to fires that destroyed two Boeing (NYSE: BA) 787 cargo planes in 2014. While the exact cause of these fires has yet to be identified, the National Transportation Safety Board openly criticized Boeing and its battery manufacturer for the faults.

In a 2013 article (http://dtn.fm/mR9i1) published by Forbes, contributor Steve Denning summarized one potential issue observed in the manufacturing process of the Boeing 787.

“Some degree of outsourcing in other countries—i.e. offshoring—is an inevitable aspect of manufacturing a complex product like an airplane, because some expertise exists only in foreign countries. For example, the capacity to manufacture Lithium-ion batteries lies outside the U.S.,” Denning stated in the article. “While there is nothing in principle wrong with necessary offshoring, the cultural and language differences and the physical distances involved in a lengthy supply chain create additional risks. Mitigating them requires substantial and continuing communications with the suppliers and on-site involvement, thereby generating additional cost.”

This practice of offshoring lithium ion battery manufacturing has led to additional quality and safety concerns in recent months. During the final months of 2015, hoverboards were established as the go-to gift for the holiday season. However, improperly manufactured lithium ion batteries and substandard quality control transformed this futuristic gift into a nightmare for dozens of families around the globe (http://dtn.fm/RLEf0).

Oakridge Global Energy Solutions, Inc. (OTCQB: OGES) is taking a proactive approach to combatting the dangers of some internationally-produced stored energy products by commercializing a full line of ‘Made in the USA’ lithium ion battery solutions. The company’s products – including its Pro Series, Patriot Series, Freedom Series and Liberty Series – are designed, manufactured and tested to strict standards directly from its state-of-the-art manufacturing facilities in Brevard Country, Florida. In the coming months, Oakridge expects to install more than 2.6 gigawatt-hours of production capacity for U.S.-manufactured electrodes, cells and batteries, creating an affordable, competitive product that gives families and businesses an opportunity to support the local economy.

With an experienced management team in place and a detailed company roadmap outlining plans to increase its presence in the rapidly expanding lithium ion battery market, Oakridge is well-positioned to usher in a new era in battery manufacturing as a leader in the ongoing ‘on-shoring’ movement. Look for the company to continue expanding upon its product line in the coming months in an effort to promote strong, sustainable returns for shareholders.

For more information, visit www.oakridgeglobalenergy.com

Let us hear your thoughts: Oakridge Global Energy Solutions, Inc. Message Board

Content Checked Holdings, Inc. (OTCQB: CNCK) continued to make progress toward increasing awareness of its innovative suite of mobile apps last week when it was named in an article published on Z Living, a leading network for health and wellness programming. In the article, titled “Foods That Sneak Sugar Into Your Weight-Loss Meal Plan,” author Menaka Warrier examines the effects of cutting out sugar when attempting to shed a few pounds. Victoria Brodsky, head of nutrition for Content Checked, contributed helpful advice regarding the true benefits of sugar-free and low-fat foods.

In the article, Brodsky warns that “sugar-free foods lure us with the prospect of eating sweets and maintaining that waistline, but over-indulging in them can be counterproductive… Their unnatural makeup of delivering sugar without the calories promotes metabolic dysfunction which causes you to store fat and leads to an increase in appetite.” Along with this advice, the article features a link to a selection of posts on the Content Checked website which provides additional information about limiting sugar intake and promoting a healthier lifestyle.

To view the full article, visit http://dtn.fm/UG3gk

Z Living is dedicated to showcasing the best of healthy lifestyle and wellness entertainment across multiple mediums – including television, the internet and on-demand streaming networks. The network’s website attracts an audience of more than 36,000 unique month visitors with a regularly updated selection of articles focusing on beauty, fitness, food and healthy lifestyle inspiration.

In recent weeks, Content Checked has leveraged the marketability of its suite of nutrition-based mobile apps – including ContentChecked, MigraineChecked and SugarChecked – to secure coverage in an assortment of popular blogs and news sites. Through these efforts, in addition to a planned rebranding of its products to be unveiled in the coming weeks, the company aims to increase its market share while continuing to improve the lives of individuals with specific dietary preferences or food-related allergies.

For more information, visit www.contentchecked.com

Let us hear your thoughts: ContentChecked Holdings Inc. Message Board

OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products. The company’s lead product candidate, ProscaVax™, is a novel prostate cancer vaccine that’s scheduled to commence a phase II clinical trial in the coming weeks after recording promising results in its phase I clinical trial, which was completed late last year.

Unlike many leading treatment options, ProscaVax is being developed to treat prostate cancer in its early stages, allowing patients to build up an immunity that helps their bodies combat the disease with little or no toxicity. OncBioMune’s revolutionary technology introduces molecules known as antigens into the body in order to stimulate an aggressive immune response before the cancer becomes too advanced. In its phase I clinical trial of ProscaVax, an impressive 70 percent of patients who received three vaccines demonstrated increased immune response to prostate-specific antigen (PSA), a protein produced by cells of the prostate gland that can aid in the early detection of prostate cancer. This result, in addition to the candidate’s exemplary safety profile, bodes well for ProscaVax moving forward.

Leveraging a proprietary vaccine technology designed to boost the immune system’s natural ability to protect the body, ProscaVax is expected to be marketable and extremely profitable upon FDA approval, potentially becoming the standard of care for prostate cancer treatment. According to data from the American Cancer Society, about 220,800 new cases of prostate cancer were diagnosed in the United States last year. In total, the disease accounts for more than 27,500 deaths each year, making it the second leading cause of cancer death in American men.

Despite its prevalence, prostate cancer remains one of the most survivable forms of cancer, with a 10-year survival rate of roughly 98 percent in cases discovered in the local or regional stages. However, survivability is greatly impacted if the disease goes undetected into an advanced stage. In cases where prostate cancer has spread to bones, organs or distant lymph nodes, the five-year survival rate drops from nearly 100 percent to just 28 percent, according to ZERO. This statistic further highlights the potential benefit of ProscaVax, particularly in early stage prostate cancer cases.

Leading market research firm BCC Research valued the global market for the prevention and treatment of prostate cancer at $26.1 billion in 2011, and the firm forecasts the market to surpass $50 billion by next year. This growth will be led by the drug therapeutics sector, which is expected to sustain an 18 percent compound annual growth rate through 2017. As OncBioMune prepares to commence its phase II clinical trial of ProscaVax, this market performance could foreshadow an opportunity for the company to achieve strong financial growth following FDA approval and commercialization of its innovative treatment option.

Through an agreement with Lincoln Park Capital Fund, OncBioMune has secured $10 million in funding with which to help finance the upcoming phase II clinical study of ProscaVax. This strong cash position, along with the early promise of the company’s cancer vaccine technologies, makes OncBioMune an attractive play in the rapidly evolving oncology space.

For more information, visit www.oncbiomune.com

Content Checked Holdings, Inc. (OTCQB: CNCK), the company behind the innovative ContentChecked, MigraineChecked and SugarChecked mobile applications, has made tremendous strides toward increasing its brand awareness in recent months by contributing helpful tidbits for living a healthier life in articles on some of the web’s top nutrition- and technology-focused news sites. Earlier this week, the company built on this progress when SugarChecked, an app that identifies four main types of sugars in products with a quick and easy barcode scan, was featured in an in-depth review article by social media and technology news site #LatinaGeeks.

In the review, Tanya M. Salcido, a #LatinaGeeks contributor, takes a closer look at the benefits of using the SugarChecked app, which she refers to as “having your own team of specialists in the palm of your hands.” After quickly discussing some of the biggest advantages of using Content Checked’s convenient shopping assistant – including the option to set personalized dietary suggestions, receive multiple healthy alternatives to sugary products and search through a database of nutritional recipes – Salcido added an impressive list of standout features offered in SugarChecked, including the fact that it is now free to download in both Google Play and the App Store.

To view the full article, visit http://dtn.fm/jTK83

Founded in 2013, #LatinaGeeks is an influential site within the Hispanic community. Its target audience is made up primarily of early adopters, social media enthusiasts, entrepreneurs, influencers, branding experts, marketing pros, Web 2.0 aficionados and technology addicts. The site has a strong social media presence – including thousands of likes and followers on Facebook and Twitter.

By continuing to secure coverage in popular media outlets, Content Checked is progressing toward its goal of uplisting to the NASDAQ or NYSE in the coming months. In a letter to shareholders, Kris Finstad, chairman and chief executive officer of Content Checked, highlighted uplisting to a major exchange as a primary goal for the company in 2016. As part of this effort, Content Checked plans to unveil a relaunch and rebrand of its products in March, introducing a new, subscription-based revenue model designed to meet the evolving preferences of its growing user base.

For more information, visit www.contentchecked.com

Let us hear your thoughts: ContentChecked Holdings Inc. Message Board

Lightlake Therapeutics, Inc. (OTCQB: LLTP) is a specialty pharmaceutical company engaged in the development of pharmacological treatments for substance abuse, addiction and eating disorders. In December 2014, the company entered into a global licensing deal with a subsidiary of Adapt Pharma Limited to develop and commercialize Lightlake’s innovative intranasal naloxone opioid overdose reversal treatment, NARCAN® Nasal Spray. As per the terms of this deal, Lightlake could receive potential development and sales milestone payments totaling more than $55 million – including a $2 million milestone payment following FDA approval and a $2.5 million milestone payment following the first commercial sale of NARCAN in the U.S. – in addition to double-digit royalty fees.

In November 2015, NARCAN was approved by the U.S. Food and Drug Administration for the emergency treatment of known or suspected opioid overdose. This approval marked the first time that naloxone –the trusted choice of healthcare providers to reverse the effects of opioid overdose for more than 40 years – was approved for distribution in the U.S. in a non-injection delivery method. Since its approval, momentum to increase access to naloxone has been on the rise. Late last year, President Obama included a call to make naloxone more readily available as part of a major initiative to address the nation’s opioid epidemic.

The commercial potential of NARCAN, to be marketed by Adapt, is expansive. In 2013, opioid overdose related deaths claimed nearly 24,500 lives in the U.S., accounting for roughly 52 percent of all drug overdose deaths, according to the Centers for Disease Control and Prevention. In total, prescription opioid abuse costs accounted for approximately $55.7 billion in 2007, with about 45 percent of all spending attributed to healthcare expenses.

In addition to its efforts to address the domestic opioid crisis, Lightlake has also completed a phase II clinical trial for its naloxone nasal spray to treat binge eating disorder (BED), a condition resulting in a lack of control when eating foods that are high in sugar, fat or salt. According to clinical data, the company’s nasal spray is well-suited to treating BED because it remains in the brain for two hours – the duration of a typical binge – without inducing negative side effects, such as a loss of interest in exercise, which are common with long-lasting opioid antagonists like naltrexone and nalmefene. Lightlake has also announced plans to conduct a Cocaine Use Disorder study in collaboration with the National Institute of Drug Abuse in the future.

With President Obama allocating $133 million toward the opioid epidemic in 2016 and guidelines from the Department of Health suggesting that naloxone could eventually become a standard script accompanying the more than 240 million opioid prescriptions written every year in the U.S., Lightlake, through its licensing deal with Adapt, is well positioned to record strong financial growth in the months to come. Look for the company to benefit from royalties stemming from this licensing agreement as it continues to advance its promising clinical pipeline targeting the treatment of BED and cocaine use disorder.

For more information, visit www.lightlaketherapeutics.com